Physiologic Newborn Jaundice – A Complete Medical Guide

Overview

Jaundice of the newborn (physiologic) is a **temporary yellow discoloration of the skin and the whites of the eyes** that occurs in most healthy infants shortly after birth. It is caused by a buildup of bilirubin, a yellow pigment produced when red blood cells break down. Unlike pathologic jaundice, physiologic jaundice is harmless, self‑limited, and usually resolves without aggressive treatment.

• Who it affects: Nearly all term and late‑preterm infants (≥35 weeks gestation) develop some degree of physiologic jaundice.
• Prevalence: Up to 60 % of term infants and 80 % of late‑preterm infants develop visible jaundice within the first week of life^¹.
• Typical timing: Peaks between day 3–5 in term babies and day 5–7 in late‑preterm infants, then declines.

Symptoms

Physiologic jaundice follows a predictable pattern. The yellow color usually appears first on the face and progresses downward.

• Skin discoloration: Yellow hue beginning on the forehead, eyelids, and nose; may spread to the chest, abdomen, and lower extremities.
• Eye involvement (icteric sclera): The whites of the eyes become yellow; often the first sign parents notice.
• Normal feeding: Babies typically feed well and maintain steady weight gain.
• Normal stool and urine output: Stools may be yellow‑green; urine is usually pale yellow.
• No other signs of illness: No fever, lethargy, poor feeding, or respiratory distress.

Causes and Risk Factors

Why bilirubin rises

During the first days of life, an infant’s liver is still maturing and can’t process bilirubin as efficiently as an adult’s liver. Additionally, newborns have a higher turnover of red blood cells (RBCs) because fetal RBCs contain fetal hemoglobin, which is replaced after birth.

Key risk factors

• Prematurity: <35 weeks gestation reduces liver enzyme activity.
• Breast‑feeding: Inadequate milk intake (breast‑milk jaundice) can increase bilirubin re‑absorption.
• Ethnicity: Higher incidence in East Asian, Mediterranean, and African ancestry due to genetic variations in bilirubin metabolism.
• Bruising or birth trauma: More RBC breakdown.
• Sibling history of severe jaundice.
• Maternal factors: Diabetes, hypertension, or medication that interferes with bilirubin conjugation.

Diagnosis

Diagnosis is clinical, supported by laboratory testing when bilirubin levels might be high.

Visual assessment

• Kramer scale: A 5‑point scale (head to toes) used to estimate the extent of skin discoloration.
• Transcutaneous bilirubinometer (TcB): Hand‑held device that estimates serum bilirubin without a blood draw.

Laboratory tests

• Serum total bilirubin (TSB): Blood sample analyzed in a laboratory; the gold standard for decision‑making.
• Direct (conjugated) vs. indirect (unconjugated) bilirubin: Physiologic jaundice is almost entirely indirect.
• Additional labs (if indicated): Blood type and Coombs test (to rule out hemolytic disease), CBC, G6PD level.

When to test

Most infants are screened at 24‑48 hours after birth, then again at 72 hours or earlier if risk factors are present. The American Academy of Pediatrics (AAP) provides nomograms that plot bilirubin level against infant age to decide if treatment is needed^².

Treatment Options

Because physiologic jaundice is self‑limited, treatment aims to **enhance bilirubin elimination** and **prevent levels from becoming hazardous**.

Phototherapy

• How it works: Blue‑green light (≈460 nm) converts bilirubin into water‑soluble isomers that can be excreted without liver processing.
• Indications: TSB exceeds age‑specific thresholds on the AAP nomogram or the infant shows rapid rise (>0.2 mg/dL per hour).
• Types: Conventional overhead lamps, fiber‑optic blankets, or LED devices. LED units are now standard due to efficiency and lower heat.
• Duration: Typically 12–24 hours, reassessed every 4–6 hours.

Enhanced feeding

• Breast‑fed infants: Offer at least **8–12 feedings per 24 hours** to promote bowel movements, which help eliminate bilirubin.
• Formula‑fed infants: Ensure adequate volume (≈150 mL/kg/day).

Intravenous immunoglobulin (IVIG)

Rarely needed for physiologic jaundice; reserved for hemolytic disease of the newborn when phototherapy is insufficient.

Exchange transfusion

Only considered for **extremely high bilirubin** (>20 mg/dL in term infants) that does not respond to phototherapy, to prevent kernicterus.

Medications

No drugs are required for physiologic jaundice. Phenobarbital was historically used to induce liver enzymes but is no longer recommended because of side‑effects.

Living with Jaundice of the Newborn (Physiologic)

Most families can manage mild jaundice at home with simple measures.

• Frequent feeds: Aim for 8–12 feeds per day; monitor diaper output (≥6 wet diapers/day).
• Skin exposure to light: While under phototherapy, keep the infant’s eyes protected with soft pads; otherwise, natural daylight (indirect sunlight) can be modestly beneficial, but avoid direct sun exposure.
• Temperature control: Keep the infant comfortably warm; overheating can worsen bilirubin levels.
• Track bilirubin: If a home TcB device is prescribed, record readings and share with your pediatrician.
• Document feeding patterns: Write down feeding times and volumes—useful for follow‑up visits.
• Stay hydrated: Encourage breast‑feeding on demand; consider expressed milk if the infant is sleepy.
• Parent education: Know the location of the “danger zone” on the AAP nomogram and when to call the provider.

Prevention

While physiologic jaundice cannot be entirely prevented, steps can reduce its severity.

• Early and regular feeding: Initiate breastfeeding within the first hour after birth and continue on demand.
• Prevent dehydration: Monitor weight loss; infants should lose <10 % of birth weight by day 3.
• Avoid excessive blood draws: Limit laboratory testing in the first week unless medically indicated.
• Maternal health optimization: Good glycemic control in diabetic mothers lowers the risk of newborn hyperbilirubinemia.
• Screen high‑risk groups: Premature infants, those with bruising, or known G6PD deficiency should receive closer bilirubin monitoring.

Complications

When physiologic jaundice is **appropriately monitored and treated**, complications are rare. However, unchecked high bilirubin can lead to serious outcomes.

• Kernicterus (bilirubin‑induced neurologic dysfunction): Bilirubin crosses the blood‑brain barrier, causing permanent damage to the basal ganglia, cerebellum, and brainstem. Incidence is <0.1 % in developed countries but remains a leading cause of preventable newborn brain injury.
• Acute bilirubin encephalopathy: Early reversible signs include lethargy, hypotonia, and high‑pitched cry.
• Breast‑feeding difficulties: If jaundice leads to poor feeding, weight loss may ensue, creating a vicious cycle.
• Readmission: About 5 % of infants discharged with mild jaundice return for phototherapy^³.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Neonatal Jaundice. Updated 2023.
2. American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022.
3. Cleveland Clinic. Neonatal Jaundice. Reviewed 2022.
4. Mayo Clinic. Jaundice in newborns. Accessed May 2024.
5. World Health Organization. Neonatal Jaundice. Fact sheet, 2023.